EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Doxorubicin-Based Chemotherapy on Renal Function: Assessing the Acute Kidney Injury by Changes in Serum Creatinine and Nephrotoxicity

Noor Kaseb Hadi, Adel S. Aqabi

Middle Eastern Cancer and Oncology Journal · 29.07.2026 · 2 (3) · 17-24

DOI: 10.61706/mecoj160235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Middle Eastern Cancer and Oncology Journal, online erschienen am 29.07.2026. Verfasst von Noor Kaseb Hadi und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The utilisation of anthracycline-based chemotherapy, most notably doxorubicin, has become a prevalent therapeutic modality in the management of diverse malignancies. Notwithstanding its therapeutic effectiveness, concerns regarding nephrotoxicity have gained prominence, as acute kidney injury (AKI) may adversely affect treatment continuity and patient outcomes. In order to evaluate the impact of doxorubicin-containing regimens on renal function, it is necessary to assess changes in serum creatinine and blood urea levels before and after treatment. Furthermore, the incidence and severity of AKI must be determined. A retrospective observational study was conducted on patients receiving doxorubicin-based chemotherapy. A comprehensive analysis encompassing demographic data, chemotherapy protocols, and renal biomarkers was conducted prior to and following treatment. The present study defined and staged AKI in accordance with the KDIGO criteria. Renal function exhibited a substantial decline following treatment. Consequently, mean serum creatinine levels exhibited an increase from 0.76 ± 0.21 mg/dL to 0.90 ± 0.22 mg/dL (p < 0.001), while blood urea levels rose from 35.28 ± 6.33 mg/dL to 37.18 ± 5.67 mg/dL (p < 0.001). The incidence of acute kidney injury (AKI) was observed in 27% of patients, predominantly in Stage I (77.6%), with Stage II accounting for 22.4%. No severe (Stage III) AKI was observed. Doxorubicin-based chemotherapy has been associated with early renal impairment and a notable incidence of AKI. It is imperative that renal biomarkers are monitored regularly in order to facilitate early detection and prevention of nephrotoxicity, thereby ensuring the safe administration of chemotherapy.

Zitieren

APA

Hadi, N. K., & Aqabi, A. S. (2026). Impact of Doxorubicin-Based Chemotherapy on Renal Function: Assessing the Acute Kidney Injury by Changes in Serum Creatinine and Nephrotoxicity. Middle Eastern Cancer and Oncology Journal, 2(3), 17-24. https://doi.org/10.61706/mecoj160235

Vancouver

Hadi NK, Aqabi AS. Impact of Doxorubicin-Based Chemotherapy on Renal Function: Assessing the Acute Kidney Injury by Changes in Serum Creatinine and Nephrotoxicity. Middle Eastern Cancer and Oncology Journal. 2026;2(3):17-24. doi:10.61706/mecoj160235

BibTeX
@article{Hadi2026,
  author = {Hadi, Noor Kaseb and Aqabi, Adel S.},
  title = {Impact of Doxorubicin-Based Chemotherapy on Renal Function: Assessing the Acute Kidney Injury by Changes in Serum Creatinine and Nephrotoxicity},
  journal = {Middle Eastern Cancer and Oncology Journal},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {17--24},
  doi = {10.61706/mecoj160235}
}
Kostenlos starten →